Investigation of Plasma Metabolic and Lipidomic Characteristics of a Chinese Cohort and a Pilot Study of Renal Cell Carcinoma BiomarkerXiaoyan Liu, Wei Sun, Mingxin Zhang et al.|Frontiers in Oncology|2020Cited by 15
MP71-18 BLUE LIGHT CYSTOSCOPY VERSUS WHITE LIGHT CYSTOSCOPY FOR THE DETECTION OF BLADDER CANCER USING MODERN HD 4K EQUIPMENT: AN ANALYSIS OF PIVOTAL TRIAL AND REAL-WORLD DATA IN CHINAHanzhong Li, Kristine Young‐Halvorsen, Jian Huang et al.|The Journal of Urology|2024Cited by 1
Phase II study of oral APL-1202 plus tislelizumab or tislelizumab alone as neoadjuvant therapy in patients with muscle-invasive bladder cancer (MIBC).Matthew D. Galsky, Xiaoliang Yuan, John P. Sfakianos et al.|Journal of Clinical Oncology|2025Cited by 1
Front & Back MatterMetin İshak Öztürk, Hoon Jang, Orhan Koca et al.|Urologia Internationalis|2012Cited by 0
Investigation of the Plasma Metabolic and Lipidomic Characteristics of a Chinese Population and Its Application in Biomarker Discovery for Renal Cell CarcinomaXiaoyan Liu, Yushi Zhang, Mingxin Zhang et al.|SSRN Electronic Journal|2019Cited by 0